OPTIMIERTES FAKTOR-VIII-GEN

Patent europeic · EP2956477 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2956477
Numer da la dumonda
EP14751254
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Mantegnì en furma midada
Annunzià
14-02-2014
Publitgà
23-12-2015
Concedì
18-11-2020
La protecziun finescha il pli tard
13-02-2034
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07K 14/755 (2006.01)
Prioritad
US 201361765626 P 15.02.2013
Dumonda PCT
PCT/US2014/016441 14.02.2014
Publicaziun PCT
WO2014/127215 21.08.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  3. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  4. 27-12-2023

    Midada

    Published in Swissreg on 27.12.2023

  5. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  6. 17-11-2021

    Midada

    Published in Swissreg on 17.11.2021

  7. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  8. 18-11-2020

    Concedì

    Published in Swissreg on 18.11.2020

Partidas

Possessur

Bioverativ Therapeutics Inc.

225 Second Avenue, Waltham, MA 02451, US

Inventur

TAN, Siyuan

Lexington, Massachusetts 02421, US

PETERS, Robert, T.

Needham, Massachusetts 02492, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.